In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: BrightSpring Health Services appears significantly overvalued, with a market price 45.7% above the PERT-weighted fair value of $33.02 and all Monte Carlo scenarios below current price. Weak efficiency and leverage scores alongside volatile DCF estimates reflect elevated investment risk. Analyst targets and trading ranges suggest some market optimism, but downside risk is notably high.